HK1046237B - 治療憂鬱症及緩和壓力的磷脂酰絲氨酸及磷脂酸 - Google Patents

治療憂鬱症及緩和壓力的磷脂酰絲氨酸及磷脂酸

Info

Publication number
HK1046237B
HK1046237B HK02107472.0A HK02107472A HK1046237B HK 1046237 B HK1046237 B HK 1046237B HK 02107472 A HK02107472 A HK 02107472A HK 1046237 B HK1046237 B HK 1046237B
Authority
HK
Hong Kong
Prior art keywords
serine
phosphatidic acid
lecithin
phosphatidyl
phosphatidy
Prior art date
Application number
HK02107472.0A
Other languages
English (en)
Other versions
HK1046237A1 (en
Inventor
David Rutenberg
Original Assignee
Lipogen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipogen Ltd filed Critical Lipogen Ltd
Publication of HK1046237A1 publication Critical patent/HK1046237A1/xx
Publication of HK1046237B publication Critical patent/HK1046237B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02107472.0A 2000-10-23 2002-10-15 治療憂鬱症及緩和壓力的磷脂酰絲氨酸及磷脂酸 HK1046237B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL139224A IL139224A (en) 2000-10-23 2000-10-23 Anti depressant, stress suppressor and mood improver

Publications (2)

Publication Number Publication Date
HK1046237A1 HK1046237A1 (en) 2003-01-03
HK1046237B true HK1046237B (zh) 2009-04-09

Family

ID=11074750

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107472.0A HK1046237B (zh) 2000-10-23 2002-10-15 治療憂鬱症及緩和壓力的磷脂酰絲氨酸及磷脂酸

Country Status (10)

Country Link
US (1) US6410522B1 (zh)
EP (1) EP1201244B1 (zh)
AT (1) ATE401898T1 (zh)
CA (1) CA2352528C (zh)
DE (1) DE60134931D1 (zh)
DK (1) DK1201244T3 (zh)
ES (1) ES2309021T3 (zh)
HK (1) HK1046237B (zh)
IL (1) IL139224A (zh)
PT (1) PT1201244E (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
ES2425114T3 (es) * 2000-03-16 2013-10-11 The Mclean Hospital Corporation CDP-colina y uridina para el tratamiento del abuso del acohol
US20050129738A1 (en) * 2002-06-16 2005-06-16 Lipogen Ltd. Infant formula supplemented with phospholipids
IL150240A (en) * 2002-06-16 2005-07-25 Lipogen Ltd Infant formula supplemented with phospholipids
US6878532B1 (en) 2003-04-28 2005-04-12 Sioux Biochemical, Inc. Method of producing phosphatidylserine
WO2005044176A2 (en) * 2003-11-10 2005-05-19 Lipogen Ltd. Compositions containing phosphatidic acid, methods of use thereof, methods of manufacture thereof, and articles of manufacture containing same
GB0400031D0 (en) 2004-01-03 2004-02-04 Univ Sheffield Depression treatment
WO2005122767A1 (en) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
EP1765364A4 (en) * 2004-06-10 2010-09-22 Mclean Hospital Corp PYRIMIDINES, SUCH AS Z: B: CYTIDINE, IN THE TREATMENT OF PATIENTS WITH BIPOLAR DISORDER
EP1784199A4 (en) * 2004-08-11 2010-06-23 Mclean Hospital Corp COMPOUNDS FOR TREATING MARIHUANA DEPENDENCE, DEDUCTION AND CONSUMPTION
EP1896074A4 (en) * 2005-05-25 2009-04-22 Liponex Inc PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CORONARY ARTERY DISEASE
IL182372A0 (en) * 2007-04-01 2008-01-20 Enzymotec Ltd Compositions containing phosphatidylserine in treating diabetes-associated conditions
US8846338B2 (en) 2008-08-07 2014-09-30 Lipogen Ltd. Processes for the preparation of phosphatides
US8546104B2 (en) 2008-08-07 2013-10-01 Lipogen Ltd. Processes for the preparation of phosphatide salts
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance
US9326961B2 (en) * 2010-02-26 2016-05-03 Coape, Ltd Diet and methods for improving learning capacity, mood and behavior in mammals
US20130064803A1 (en) * 2011-09-14 2013-03-14 Naidu Lp BIO-REPLENISHMENT (BioRep) FOR COGNITIVE HEALTH
DK2769725T3 (en) * 2013-02-22 2016-08-22 Lipogen Ltd PREPARATIONS FOR USE AT relief of symptoms associated with premenstrual syndrome and premenstrual dysphoric disorder
EP2881104A1 (en) 2013-12-05 2015-06-10 Lonza Ltd Use of compositions comprising phosphatidylserine and phosphatidic acid and/or salts thereof for reducing or preventing sweating

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4117629A1 (de) * 1991-05-29 1992-12-03 Max Planck Gesellschaft Phospatidylserine
US5700668A (en) * 1995-12-08 1997-12-23 Italfarmaco Sud S.P.A. Process for the industrial preparation of phosphatidylserine
IL118180A (en) * 1996-05-08 2000-12-06 Modus Biolog Membranes Ltd Pharmaceutical compositions comprising a phosphatidic acid (PA) enriched natural phospholipid preparation and the production of such preparation

Also Published As

Publication number Publication date
CA2352528C (en) 2005-12-06
DK1201244T3 (da) 2008-11-17
ATE401898T1 (de) 2008-08-15
US20020072508A1 (en) 2002-06-13
CA2352528A1 (en) 2002-04-23
DE60134931D1 (de) 2008-09-04
ES2309021T3 (es) 2008-12-16
EP1201244A2 (en) 2002-05-02
HK1046237A1 (en) 2003-01-03
IL139224A (en) 2009-09-01
PT1201244E (pt) 2008-09-23
EP1201244A3 (en) 2003-12-10
EP1201244B1 (en) 2008-07-23
US6410522B1 (en) 2002-06-25

Similar Documents

Publication Publication Date Title
HK1046237A1 (en) Phosphatidyl-l-serine and phosphatitic acid for treating depression and releaving stress
CA2162232A1 (en) Cerebration improver
BRPI0508584A (pt) lipìdio estruturado contendo composições e métodos com caracterìsticas promotoras de saúde e nutrição
PT1343385E (pt) Composicao alimentar apropriada para fritura superficial compreendendo lecitina de girassol
BRPI0512864B8 (pt) composição oftálmica, uso de pelo menos um ácido graxo ômega-6 e pelo menos um ácido graxo ômega-3 e método para preparar a referida composição
BR0214838A (pt) Composição para promoção de crescimento ósseo e manutenção da saúde óssea
BR9815832A (pt) Composição de proteìna vegetal contendo um material de proteìna vegetal exaurido de isoflavona com um material contendo isoflavona
ATE297726T1 (de) Forskolin zur entwicklung magerer körpermasse
ATE514345T1 (de) Zusammensetzung zur senkung des blutcholesterolspiegels
AR025141A1 (es) Esteres de fitoesterol y/o fitoestanol obtenidos a partir de fitoesteroles y/o fitoestanol con acidos grasos poliinsaturados, un proceso para su obtencion, empleo de dichos esteres para la manufactura de una comida dietetica para la dieta humana y para formulaciones, y dichas formulaciones
ATE492618T1 (de) Herstellung von speiseöl mit hohem diglyceridgehalt
ES2151598T3 (es) Productos de tabaco o sustancias similares a dichos productos que contienen sustancias naturales de accion antioxidante, y su procedimiento de fabricacion.
ATE292460T1 (de) Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels
DE69825003D1 (de) Verfahren zur Herstellung und Verwendung von Phytochemikalien
DE69816568D1 (de) Neue verwendung von phospholipiden tierischen ursprungs in der therapie und/oder schonkost
NO20076382L (no) Anvendelse av dokosaheksaenglyserider i behandlingen av tumorese sykdommer
BR0112919A (pt) Uso de óleos essenciais para combater infecção do trato gi por organismos semelhantes a helicobacter
ATE387861T1 (de) Zusammmensetzung enthaltend resistente stärke und ungesättigte fette
BRPI0309421A8 (pt) Método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
ATE397058T1 (de) In vitro rekonstituierte lagen des menschlichen hornhautepithels und verfahren zur herstellung davon
ATE384446T1 (de) PHARMAZEUTISCHE- UND NAHRUNGSMITTELZUSAMMENZETZUNGEN MIT ßHOLZALKOHOLß UND ßHOLZSTEROLß ZUR SENKUNG DES SERUMCHOLESTERINS
DE59002572D1 (de) Omega-3-fettsäurenhaltige fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung.
BRPI0210463A8 (pt) Extratos de bauhínia
Sengupta et al. Antioxidant and hypocholesterolemic properties of functional soy yogurts fortified with ω‐3 and ω‐6 polyunsaturated fatty acids in Balb/c mice
ATE228556T1 (de) An omega-3 ungesättigten fettsäuren angereicherte wachsester, ihre herstellung und verwendung

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130628